Deciphera Pharmaceuticals DCPH

$ 25.59 0.0%

Annual report 2023
added 02-07-2024

Deciphera Pharmaceuticals Financial Statements 2011-2024 | DCPH

Annual Financial Statements Deciphera Pharmaceuticals

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	1.2 B	1.24 B	448 M	2.44 B	2.74 B	933 M	443 M	-	-	-	-	-	-
Shares	85.1 M	75.5 M	58.1 M	55.8 M	42.9 M	35.4 M	16.8 M	-	-	-	-	-	-
Historical Prices	14.1	16.4	7.71	43.8	53.2	28.4	25	-	-	-	-	-	-
Net Income	-195 M	-179 M	-300 M	-266 M	-192 M	-99.9 M	-50.3 M	-25.9 M	-19.8 M	-	-	-	-
Revenue	163 M	134 M	96.1 M	42.1 M	25 M	-	-	-	-	-	-	-	-
Cost of Revenue	3.73 M	8.77 M	2.93 M	225 K	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-211 M	-183 M	-300 M	-271 M	-201 M	-104 M	-50.9 M	-25.8 M	-17.6 M	-	-	-	-
Interest Expense	16.4 M	4.51 M	113 K	4.7 M	67 K	84 K	95 K	106 K	2.21 M	-	-	-	-
EBITDA	-209 M	-180 M	-297 M	-269 M	-200 M	-104 M	-50.8 M	-25.7 M	-17.5 M	-	-	-	-
Operating Expenses	-	-	-	-	226 M	104 M	50.9 M	-	-	-	-	-	-
General and Administrative Expenses	136 M	120 M	136 M	114 M	68.1 M	21.2 M	11.4 M	5.68 M	5.14 M	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Deciphera Pharmaceuticals

	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	85.8 M	85 M	82.7 M	67.6 M	78.2 M	72.1 M	58.6 M	58.5 M	58.1 M	58 M	57.7 M	57.6 M	56.4 M	55.9 M	53.6 M	51.6 M	43.8 M	38.2 M	38.1 M	37.7 M	37.7 M	33.6 M	32.6 M	32.6 M	11.6 M	11.6 M	11.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-49.6 M	-48.6 M	-49.6 M	-	-43 M	-43.1 M	-46.9 M	-	-79.8 M	-70.4 M	-300 M	-62.7 M	-266 M	-266 M	-266 M	-67.2 M	-192 M	-192 M	-192 M	-32.3 M	-99.9 M	-99.9 M	99.9 M	-19.9 M	-50.3 M	-50.3 M	-50.3 M	-8.56 M	-6.1 M	-5.93 M	-5.35 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	43.3 M	38.3 M	33.4 M	-	36 M	32.5 M	29.2 M	-	23.2 M	23.6 M	25.2 M	19.5 M	15.4 M	7.09 M	62 K	-	-	25 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	1.29 M	173 K	488 K	-	3.34 M	1.8 M	382 K	-	917 K	1.28 M	222 K	-	90 K	8 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	19.4 M	15.4 M	7.08 M	62 K	-	-	25 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-53.7 M	-52.8 M	-53.3 M	-	-44.9 M	-43.8 M	-46.9 M	-	-79.7 M	-70.5 M	-61.5 M	-63 M	-64 M	-68.9 M	-75.3 M	-70.4 M	-58.4 M	-23 M	-49 M	-33.8 M	-25.9 M	-22.4 M	-22 M	-20.3 M	-12.2 M	-10.7 M	-7.72 M	-8.53 M	-6.07 M	-5.91 M	-5.32 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	4.11 M	4.21 M	3.65 M	-	1.84 M	727 K	-	-	-170 K	81 K	196 K	-	-	-	-	-	17 K	25 K	13 K	-	21 K	21 K	22 K	-	23 K	24 K	25 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-52.6 M	-	-42.5 M	-43.8 M	-46.1 M	-	-77.4 M	-70.5 M	-60.8 M	-63 M	-62.4 M	-68 M	-74.8 M	-70.4 M	-58 M	-22.8 M	-48.9 M	-33.8 M	-25.7 M	-22.3 M	-21.9 M	-20.3 M	-12.1 M	-10.6 M	-7.69 M	-8.53 M	-6.07 M	-5.91 M	-5.32 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	75.3 M	-	58.4 M	48 M	49 M	-	25.9 M	22.4 M	22 M	-	12.2 M	10.7 M	7.73 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	33.3 M	32.6 M	31.4 M	-	30 M	29.6 M	28.3 M	-	35.5 M	32.8 M	30.7 M	-	30.1 M	29.9 M	23.9 M	-	18 M	13.2 M	13.2 M	-	5.26 M	4.45 M	5.03 M	-	2.43 M	2.24 M	2.07 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency